(Q34397284)

1 August 2017

1 reference

title

Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives (English)

1 reference

1 August 2017

1 reference

Anne Zeleniuch-Jacquotte

series ordinal

2

1 reference

1 August 2017

Akhmedkhanov A

1

1 reference

PubMed ID

11594550

1 August 2017

Toniolo P

series ordinal

3

1 reference

PubMed ID

11594550

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Annals of the New York Academy of Sciences

1 August 2017

1 reference

1 August 2017

943

1 reference

1 August 2017

296-315

1 reference

Increasing Incidence of Endometrial Cancer in the United States

1 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Association of Exogenous Estrogen and Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Trends in the incidence of endometrial cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Diabetes and endometrial cancer: an Italian case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Cancer incidence in a cohort of infertile women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

A case-control study of cancer of the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Estrogen-progestin replacement therapy and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Childbearing at older age and endometrial cancer risk (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Selected physical activities and the risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Physical activity and postmenopausal endometrial cancer risk (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

21 January 2018

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Assessing obesity: classification and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Obesity in women from developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Source of Estrogen Production in Postmenopausal Women1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Sex-hormone-binding globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer--preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Risk of endometrial cancer after tamoxifen treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Production of Estrone and Fractional Conversion of Circulating Androstenedione to Estrone in Women with Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Plasma estrogen in patients with endometrial hyperplasia and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Serum Levels of Total Dehydroepiandrosterone and Total Estrone in Postmenopausal Women with Special Regard to Carcinoma of the Uterine Corpus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Hormonal profile of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Serum estrogens and androgens in women with endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Is there an altered steroid profile in patients with endometrial carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

The relationship between oestradiol metabolism and adrenal steroids in the endometrium of postmenopausal women with and without endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Case-control study of endogenous steroid hormones and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Theories of endometrial carcinogenesis: a multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

The Hormonal Activity of the Postmenopausal Ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Increased bioactive luteinizing hormone levels in postmenopausal women with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Decidua: a possible source of amniotic fluid prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Prolactin and its receptor in human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Insulin resistance, insulin-like growth factor I and breast cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

The gonadotropic function of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Regulation of epidermal growth factor and insulin-like growth factor I receptors by estradiol and progesterone in normal and neoplastic endometrial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

Insulin-like growth factors in endometrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2001.TB03811.X

10.1111/J.1749-6632.2001.TB03811.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11594550